High‐Contrast Imaging of α‐Synuclein Pathologies in Living Patients with Multiple System Atrophy

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 37; no. 10; pp. 2159 - 2161
Main Authors Matsuoka, Kiwamu, Ono, Maiko, Takado, Yuhei, Hirata, Kosei, Endo, Hironobu, Ohfusa, Toshiyuki, Kojima, Taichi, Yamamoto, Takeshi, Onishi, Tomohiro, Orihara, Asumi, Tagai, Kenji, Takahata, Keisuke, Seki, Chie, Shinotoh, Hitoshi, Kawamura, Kazunori, Shimizu, Hiroshi, Shimada, Hitoshi, Kakita, Akiyoshi, Zhang, Ming‐Rong, Suhara, Tetsuya, Higuchi, Makoto
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.10.2022
Wiley Subscription Services, Inc
Subjects
alpha-Synuclein - metabolism
Atrophy
Brain - pathology
Humans
Letters: New Observation
Movement disorders
multiple system atrophy
Multiple System Atrophy - diagnostic imaging
Multiple System Atrophy - pathology
Neuroimaging
PET
Regular Issue
Synuclein
Synucleinopathies
α‐synuclein
multiple system atrophy
PET
α-synuclein
neuroimaging
Online AccessGet full text

Cover

More Information
Bibliography:This study was supported by Eisai Co., Ltd., Takeda Pharmaceutical Company Limited, Ono Pharmaceutical Co. Ltd., Japan Science and Technology Agency (JST) (JPMJMS2024 to M.H.), and Japan Agency for Medical Research and Development (AMED) (JP19dm0207072 and 18K07777 to M.H. and 21wm0425015).
M.O., M.R.Z., and M.H. are inventors of a patent application in relation to the imaging agent documented in this report (PCT/JP2021/30899).
Funding agency
Relevant conflicts of interest/financial disclosures
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
Funding agency: This study was supported by Eisai Co., Ltd., Takeda Pharmaceutical Company Limited, Ono Pharmaceutical Co. Ltd., Japan Science and Technology Agency (JST) (JPMJMS2024 to M.H.), and Japan Agency for Medical Research and Development (AMED) (JP19dm0207072 and 18K07777 to M.H. and 21wm0425015).
Relevant conflicts of interest/financial disclosures: M.O., M.R.Z., and M.H. are inventors of a patent application in relation to the imaging agent documented in this report (PCT/JP2021/30899).
ISSN:0885-3185
1531-8257
DOI:10.1002/mds.29186